Marker gets $1.6M NIH grant to further screening technology

03/15/2012 | GenomeWeb Daily News (free registration)

The NIH's National Institute of Neurological Disorders and Stroke awarded Marker Gene Technologies a Phase II small business innovation research grant to help advance its screening technology for lysosomal storage disease drugs. Marker will use the three-year grant worth $1.6 million to develop live cell and tissue tests for drug candidates.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI